Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo


Our Turbhe, India facility has been focused on peptide APIs for the last 40 years, offering a legacy of strong capabilities in peptide chemistry. We are now one of the few pure-play peptide API companies in the world. Our world-class peptide development and manufacturing site is spread across 4,631 square meters.

Location Address:

Piramal Pharma Solutions, C-43, MIDC, T.T.C. Industrial Area, Next to Effort B.P.O, Opp Nocil RCD, Turbhe, off Thane- Belapur Road, Dist. Thane, Turbhe, Navi Mumbai-400613

Featured Services

  • R&D Capabilities:
      • Synthetic and Medicinal Chemistry
      • Process IP evaluation, development of non-infringing processes & cost effective synthesis routes
      • Isolation of impurities from API
      • Manufacturing of fragments and intermediates
  • Manufacturing Capabilities:
      • Solid- and solution-phase peptide synthesis with strong capability in downstream processing
      • Manufacturing of cost-effective pseudo-proline building blocks
      • Manufacturing of long chain peptide API’s
      • Acidic and ammonia-based cleavages and deprotections
      • Effective management of HBr and Z group deblocking
      • Industrial purification of complex peptide mixtures
      • Impurity profiling of finished product
      • Freeze drying peptide products of all complexities

Specialized Capabilities

  • Niche offerings of low-volume, high value products
  • Dedicated lines for desmopressin, leuprolide and oxytocin
  • 14 independent synthetic production lines
  • 50 litre reaction vessels for solid phase synthesis
  • Up to 2000 litre tanks for synthetic modifications and downstream processing
  • Current solid support phase capacity: 85-120 kg
  • State-of-the-art API development and analytical lab

Salient Features:

  • 11 downstream processing lines; 7 preparative HPLC lines
  • Dedicated HVAC system with class 1000 and 100 areas
  • US FDA, EDQM and KFDA approved manufacturing facility